ArticleJournal of hematology & oncology2017

Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China.

Yuankai Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.